Gilead Ulcerative Colitis Drug: Phase 3 Planned for 2027
Gilead ulcerative colitis drug emvistegrast met its Phase 2 goal; Phase 3 is planned for 2027 and combinations are in view. What is and is not known.
Tag: SWIFT clinical trial
Read More